4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-21-018629
Interim CEO acquired 90,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hagen Heidi Interim CEO | 2021-03-04 | Grant or award | +90,000 | 122,119 | D | ||
| Derivatives | |||||||
| Hagen Heidi Interim CEO | 2021-03-04 | Grant or award · Employee Stock Option (right to buy) | +675,000 | 675,000 | D | ||
Loading xslF345X03/doc4.xml…